Results 101 to 110 of about 7,708 (214)

Prolactinoma Concomitante a un Caso de Glaucoma Primario de Ángulos Abiertos, a propósito de un Caso

Revista Oftálmica
En la práctica clínica oftalmológica diaria es frecuente evaluar pacientes que presentan Glaucoma primario de ángulos abiertos1,2. En algunos casos se pueden presentar adicionalmente lesiones en nervio óptico de origen intracraneal4.
Oscar Guillermo Márquez Valdez
doaj   +1 more source

Body fat in men with prolactinoma

, 2008
OBJECTIVE: (a) To evaluate body fat in men with prolactinoma and healthy controls, using whole body dual energy x-ray absorptiometry (DXA), and (b) to correlate DXA results with anthropometry and clinical aspects of male prolactinomas.
A. Lamounier Filho, E. C. Naliato, GACCIONE, MARIA, COLAO, ANNAMARIA, Y. Schrank, D. Caldas, C. R. Loureiro, A. H. Violante, R. Fontes, F. S. Costa   +9 more
core  

Nonalcoholic Fatty Liver Disease, Bone and Muscle Quality in Prolactinoma: A Pilot Study

Objective: Hyperprolactinemia has negative impacts on metabolism and musculoskeletal health. In this study, individuals with active prolactinoma were evaluated for nonalcoholic fatty liver disease (NAFLD) and musculoskeletal health, which are ...
Eroğlu, İmdat, Akata, Deniz, Erkoc, Aysegul, Yüce, Deniz, Iremli, Burcin Gonul, Çalık Kütükcü, Ebru, Erbas, Tomris, İdilman, İlkay Sedakat   +7 more
core   +1 more source

Prolactinoma and pregnancy – a series of cases including pituitary apoplexy

, 2017
The objective of this article is to evaluate the impact of pregnancy in women with prolactinoma, the possible consequences of therapy maintenance/discontinuation during pregnancy and to assess the type of delivery and maternal–foetal obstetrical outcome.
Ana Galvão, Marta Moreira, Jorge Braga, Daniela Gonçalves, Clara Silva, Gonçalo Inocêncio   +5 more
core   +1 more source

Amyotrophic lateral sclerosis and prolactinoma

, 2007
A 59-year-old male with amyotrophic lateral sclerosis is presented. Investigations revealed the co-existence of a pituitary adenoma of the prolactinoma type This combination has not been reported before.
Stamboulis, Elevtherios, Markou, Ioannis, Gkiatas, Konstantinos, Kararizou, Evangelia, Alevizaki, Maria   +4 more
core   +1 more source

Características clínicas e presencia de prolactinoma em mulheres com hiperprolactinemia

, 2016
Objectives: To clinically characterize women with hyperprolactinemia at InSer Pereira (Colombia) and to determine the prevalence of prolactinoma.
Piedrahíta-Gutiérrez, Dany Leandro, Henao-Flórez, Rodrigo Eduardo, Gaviria-Maya, Juan Esteban, López-Clavijo, Carlos Alberto   +3 more
core   +1 more source

Cholesterol-activated stress granules reduce the membrane localization of DRD2 and promote prolactinoma dopamine agonists resistance

Acta Neuropathologica Communications
Prolactinoma is the most prevalent pituitary neuroendocrine tumor and dopamine agonists (DAs) targeting dopamine D2 receptor (DRD2) are recommended as the first-line treatment. However, varying degrees of DA resistance limit patient benefit.
Yuyang Peng, Huachun Yin, Xiangdong Pei, Yuan Zhang, Chengcheng Wang, Xin Zheng, Hong Liang, Hui Yang, Song Li   +8 more
doaj   +1 more source

Prolactinoma

Prolactinomas are benign pituitary tumors characterized by excessive secretion of prolactin. While more common in females, these tumors can also significantly impact male patients, leading to symptoms such as hypogonadism, infertility and gynecomastia.
Yatavelli RKR, Kaur J, Bhusal K.
europepmc   +2 more sources

Bone density in women with prolactinoma treated with dopamine agonists.

, 2008
Objectives (1) to evaluate bone density in women with prolactinoma treated with dopamine agonists and healthy controls, using dual energy x-ray absorptiometry (DXA), (2) to classify the results according to the current International Society for Clinical ...
A. Lamounier Filho, M. L. Farias, T. Loures, E. C. Naliato, COLAO, ANNAMARIA, Y. Schrank, D. Caldas, C. R. Loureiro, A. H. Violante, I. Bussade, R. Fontes   +10 more
core  

Insulin resistance and androgen levels in eugonadic and hypogonadic women with prolactinoma

, 2016
BACKGROUND: Hyperprolactinemia is the most common endocrinologic disorder in causing menstrual irregularities. Although the correlation between hyperprolactinemia and menstrual dysfunction is widely known, the etiology of menstrual cycle disorders is not
Arduc, Ayse, Nasiroglu, Narin I., Basaran, Mehtap N., Berker, Dilek, Dogan, Bercem A., Tuna, Mazhar M., Karakilic, Ersen   +6 more
core   +1 more source